4-[3-[4-(5-chlorothiophen-2-yl)-2H-pyrazolo[3,4-b]pyridin-3-yl]-2-pyridinyl]morpholine;N-(2,2-difluorocyclopropyl)-4-thiophen-3-yl-1H-pyrazolo[3,4-b]pyridin-3-amine;3-(2,4-dimethoxyphenyl)-4-thiophen-3-yl-2H-pyrazolo[3,4-b]pyridine;N-[3-fluoro-4-(4-methylpiperazin-1-yl)phenyl]-4-thiophen-3-yl-2H-pyrazolo[3,4-b]pyridin-3-amine;3-(2-methoxyphenyl)-4-(4-pyrrolidin-1-ylsulfonylphenyl)-2H-pyrazolo[3,4-b]pyridine;N-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]-4-thiophen-3-yl-2H-pyrazolo[3,4-b]pyridin-3-amine
C116H108ClF3N28O6S6 — CID 157096452
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-[3-[4-(5-chlorothiophen-2-yl)-2H-pyrazolo[3,4-b]pyridin-3-yl]-2-pyridinyl]morpholine;N-(2,2-difluorocyclopropyl)-4-thiophen-3-yl-1H-pyrazolo[3,4-b]pyridin-3-amine;3-(2,4-dimethoxyphenyl)-4-thiophen-3-yl-2H-pyrazolo[3,4-b]pyridine;N-[3-fluoro-4-(4-methylpiperazin-1-yl)phenyl]-4-thiophen-3-yl-2H-pyrazolo[3,4-b]pyridin-3-amine;3-(2-methoxyphenyl)-4-(4-pyrrolidin-1-ylsulfonylphenyl)-2H-pyrazolo[3,4-b]pyridine;N-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]-4-thiophen-3-yl-2H-pyrazolo[3,4-b]pyridin-3-amine
4-[3-[4-(5-chlorothiophen-2-yl)-2H-pyrazolo[3,4-b]pyridin-3-yl]-2-pyridinyl]morpholine;N-(2,2-difluorocyclopropyl)-4-thiophen-3-yl-1H-pyrazolo[3,4-b]pyridin-3-amine;3-(2,4-dimethoxyphenyl)-4-thiophen-3-yl-2H-pyrazolo[3,4-b]pyridine;N-[3-fluoro-4-(4-methylpiperazin-1-yl)phenyl]-4-thiophen-3-yl-2H-pyrazolo[3,4-b]pyridin-3-amine;3-(2-methoxyphenyl)-4-(4-pyrrolidin-1-ylsulfonylphenyl)-2H-pyrazolo[3,4-b]pyridine;N-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]-4-thiophen-3-yl-2H-pyrazolo[3,4-b]pyridin-3-amine (PubChem CID 157096452) has the molecular formula C116H108ClF3N28O6S6 and a molecular weight of 2275.18 g/mol. Its IUPAC name is 4-[3-[4-(5-chlorothiophen-2-yl)-2H-pyrazolo[3,4-b]pyridin-3-yl]-2-pyridinyl]morpholine;N-(2,2-difluorocyclopropyl)-4-thiophen-3-yl-1H-pyrazolo[3,4-b]pyridin-3-amine;3-(2,4-dimethoxyphenyl)-4-thiophen-3-yl-2H-pyrazolo[3,4-b]pyridine;N-[3-fluoro-4-(4-methylpiperazin-1-yl)phenyl]-4-thiophen-3-yl-2H-pyrazolo[3,4-b]pyridin-3-amine;3-(2-methoxyphenyl)-4-(4-pyrrolidin-1-ylsulfonylphenyl)-2H-pyrazolo[3,4-b]pyridine;N-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]-4-thiophen-3-yl-2H-pyrazolo[3,4-b]pyridin-3-amine.
Molecular Properties
| Compound Name | 4-[3-[4-(5-chlorothiophen-2-yl)-2H-pyrazolo[3,4-b]pyridin-3-yl]-2-pyridinyl]morpholine;N-(2,2-difluorocyclopropyl)-4-thiophen-3-yl-1H-pyrazolo[3,4-b]pyridin-3-amine;3-(2,4-dimethoxyphenyl)-4-thiophen-3-yl-2H-pyrazolo[3,4-b]pyridine;N-[3-fluoro-4-(4-methylpiperazin-1-yl)phenyl]-4-thiophen-3-yl-2H-pyrazolo[3,4-b]pyridin-3-amine;3-(2-methoxyphenyl)-4-(4-pyrrolidin-1-ylsulfonylphenyl)-2H-pyrazolo[3,4-b]pyridine;N-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]-4-thiophen-3-yl-2H-pyrazolo[3,4-b]pyridin-3-amine |
|---|---|
| PubChem CID | 157096452 |
| Molecular Formula | C116H108ClF3N28O6S6 |
| Molecular Weight | 2275.18 g/mol |
| Exact Mass | 2272.70 |
| IUPAC Name | 4-[3-[4-(5-chlorothiophen-2-yl)-2H-pyrazolo[3,4-b]pyridin-3-yl]-2-pyridinyl]morpholine;N-(2,2-difluorocyclopropyl)-4-thiophen-3-yl-1H-pyrazolo[3,4-b]pyridin-3-amine;3-(2,4-dimethoxyphenyl)-4-thiophen-3-yl-2H-pyrazolo[3,4-b]pyridine;N-[3-fluoro-4-(4-methylpiperazin-1-yl)phenyl]-4-thiophen-3-yl-2H-pyrazolo[3,4-b]pyridin-3-amine;3-(2-methoxyphenyl)-4-(4-pyrrolidin-1-ylsulfonylphenyl)-2H-pyrazolo[3,4-b]pyridine;N-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]-4-thiophen-3-yl-2H-pyrazolo[3,4-b]pyridin-3-amine |
| SMILES | CN1CCN(Cc2ccc(Nc3[nH]nc4nccc(-c5ccsc5)c34)cc2)CC1.CN1CCN(c2ccc(Nc3[nH]nc4nccc(-c5ccsc5)c34)cc2F)CC1.COc1ccc(-c2[nH]nc3nccc(-c4ccsc4)c23)c(OC)c1.COc1ccccc1-c1[nH]nc2nccc(-c3ccc(S(=O)(=O)N4CCCC4)cc3)c12.Clc1ccc(-c2ccnc3n[nH]c(-c4cccnc4N4CCOCC4)c23)s1.FC1(F)CC1Nc1n[nH]c2nccc(-c3ccsc3)c12 |
| InChI | InChI=1S/C23H22N4O3S.C22H24N6S.C21H21FN6S.C19H16ClN5OS.C18H15N3O2S.C13H10F2N4S/c1-30-20-7-3-2-6-19(20)22-21-18(12-13-24-23(21)26-25-22)16-8-10-17(11-9-16)31(28,29)27-14-4-5-15-27;1-27-9-11-28(12-10-27)14-16-2-4-18(5-3-16)24-22-20-19(17-7-13-29-15-17)6-8-23-21(20)25-26-22;1-27-7-9-28(10-8-27)18-3-2-15(12-17(18)22)24-21-19-16(14-5-11-29-13-14)4-6-23-20(19)25-26-21;20-15-4-3-14(27-15)12-5-7-21-18-16(12)17(23-24-18)13-2-1-6-22-19(13)25-8-10-26-11-9-25;1-22-12-3-4-14(15(9-12)23-2)17-16-13(11-6-8-24-10-11)5-7-19-18(16)21-20-17;14-13(15)5-9(13)17-12-10-8(7-2-4-20-6-7)1-3-16-11(10)18-19-12/h2-3,6-13H,4-5,14-15H2,1H3,(H,24,25,26);2-8,13,15H,9-12,14H2,1H3,(H2,23,24,25,26);2-6,11-13H,7-10H2,1H3,(H2,23,24,25,26);1-7H,8-11H2,(H,21,23,24);3-10H,1-2H3,(H,19,20,21);1-4,6,9H,5H2,(H2,16,17,18,19) |
| InChIKey | AFGNSPBIBUHSAE-UHFFFAOYSA-N |
| XLogP | 24.70 |
| TPSA | 388.90 Ų |
| H-Bond Donors | 9 |
| H-Bond Acceptors | 32 |
| Rotatable Bonds | 24 |
| Heavy Atoms | 160 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2275.18 |
| LogP ≤ 5 | 24.70 |
| H-Bond Donors ≤ 5 | 9 |
| H-Bond Acceptors ≤ 10 | 32 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'anil_di_alk_A(478)', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 157096452 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.